Cases & Deals

Boca Pharmacal acquired by Endo Health for $225 million

Clients Boca Life Science Holdings, LLC and Boca Pharmacal, LLC

Jones Day advised Boca Life Science Holdings, LLC and Boca Pharmacal, LLC in regards to the sale of all the outstanding limited liability company membership interests of Boca Pharmacal, LLC to Generics International (US) Inc., an Endo Health Solutions' subsidiary, for $225 million in cash.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.